Altered mean platelet volume (MPV) is found in several malignancies. Remarkably, there is
little consensus on using the value of MPV in the prognostic evaluations of renal cell …

Objectives: Multiple blood parameters are used to determine the prognosis of renal cell
carcinoma (RCC). Mean platelet volume/platelet count (MPV/PC) ratio is related to disease …

Background Renal cell carcinoma (RCC) is the third most common genitourinary cancer.
Activated platelets play a pivotal role in cancer development and progression. Altered mean …

Purpose The average size of blood platelets determined by mean platelet volume might
represent a biologically meaningful parameter in carcinogenesis and potentially serve as a …

Introduction Renal cell carcinoma is a highly aggressive malignancy that causes significant
morbidity and mortality. The rising number of newly diagnosed renal tumors results in a …

Altered mean platelet volume (MPV) is implicated in several malignancies. However, the
clinicopathological significance and prognostic value of MPV in colorectal cancer (CRC) is …

Objective Elevated platelet count (PC), a measure of systemic inflammatory response, is
inconsistently reported to be associated with poor prognosis in patients with renal cell …

The aim of this study was to elucidate the diagnostic and prognostic roles of the mean
platelet volume (MPV) in various malignant tumors through a systematic review and meta …

Conflicting evidence exists regarding the effect of platelet to lymphocyte ratio (PLR) and
lymphocyte to monocyte ratio (LMR) on the prognosis of renal cell carcinoma (RCC) …

Inflammatory proteins activate platelets, which have been observed to be directly related to
cancer progression and development. The aim of this systematic review is to investigate the …